Global Methane Mitigation Vaccine Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Methane Mitigation Vaccine market size was valued at US$ 72.13 million in 2025 and is forecast to a readjusted size of US$ 171 million by 2032 with a CAGR of 13.3% during review period.
Methane Mitigation Vaccine refers to a new type of biotechnology product that aims to reduce methane emissions produced by ruminants (such as cattle, sheep, etc.) during digestion through an immune mechanism. The research and development goal of this vaccine is to address the contribution of the agricultural sector, especially animal husbandry, to climate change, especially methane produced by ruminants, which is a potent greenhouse gas. Methane emission reduction vaccine is a biological agent that reduces methane production by stimulating the immune system of ruminants and reducing the activity of certain microorganisms in the intestine (mainly methane-producing archaea).
The Methane Mitigation Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Methane Mitigation Vaccine market is split by Type and by Application. For the period 2026-2032, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type,
North America
Europe
Asia-Pacific (China, Japan, South Korea, Rest of Asia)
South America
Middle East & Africa
Methane Mitigation Vaccine refers to a new type of biotechnology product that aims to reduce methane emissions produced by ruminants (such as cattle, sheep, etc.) during digestion through an immune mechanism. The research and development goal of this vaccine is to address the contribution of the agricultural sector, especially animal husbandry, to climate change, especially methane produced by ruminants, which is a potent greenhouse gas. Methane emission reduction vaccine is a biological agent that reduces methane production by stimulating the immune system of ruminants and reducing the activity of certain microorganisms in the intestine (mainly methane-producing archaea).
The Methane Mitigation Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Methane Mitigation Vaccine market is split by Type and by Application. For the period 2026-2032, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type,
- Vaccines Targeting Methane-producing Archaea
- Vaccines Modulating Immune Responses
- Cattle
- Sheep
- Other Ruminants
- Lucidome Bio
- ArkeaBio
North America
Europe
Asia-Pacific (China, Japan, South Korea, Rest of Asia)
South America
Middle East & Africa
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Methane Mitigation Vaccine
1.2 Classification of Methane Mitigation Vaccine by Type
1.2.1 Overview: Global Methane Mitigation Vaccine Market Size by Type: 2026 Versus 2032
1.2.2 Global Methane Mitigation Vaccine Revenue Market Share by Type in 2032
1.2.3 Vaccines Targeting Methane-producing Archaea
1.2.4 Vaccines Modulating Immune Responses
1.3 Global Methane Mitigation Vaccine Market by Application
1.3.1 Overview: Global Methane Mitigation Vaccine Market Size by Application: 2026 Versus 2032
1.3.2 Cattle
1.3.3 Sheep
1.3.4 Other Ruminants
1.4 Global Methane Mitigation Vaccine Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
1.5.1 Methane Mitigation Vaccine Market Drivers
1.5.2 Methane Mitigation Vaccine Market Restraints
1.5.3 Methane Mitigation Vaccine Trends Analysis
2 COMPANY PROFILES
2.1 Lucidome Bio
2.1.1 Lucidome Bio Details
2.1.2 Lucidome Bio Major Business
2.1.3 Lucidome Bio Methane Mitigation Vaccine Product and Solutions
2.1.4 Lucidome Bio Recent Developments and Future Plans
2.2 ArkeaBio
2.2.1 ArkeaBio Details
2.2.2 ArkeaBio Major Business
2.2.3 ArkeaBio Methane Mitigation Vaccine Product and Solutions
2.2.4 ArkeaBio Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Methane Mitigation Vaccine Revenue and Share by Players (2026 & 2032)
3.2 Methane Mitigation Vaccine Players Head Office, Products and Services Provided
3.3 Methane Mitigation Vaccine Mergers & Acquisitions
3.4 Methane Mitigation Vaccine New Entrants and Expansion Plans
4 GLOBAL METHANE MITIGATION VACCINE FORECAST BY REGION
4.1 Global Methane Mitigation Vaccine Market Size by Region: 2026 VS 2032
4.2 Global Methane Mitigation Vaccine Market Size by Region, (2026-2032)
4.3 North America
4.3.1 Key Companies of Methane Mitigation Vaccine in North America
4.3.2 Current Situation and Forecast of Methane Mitigation Vaccine in North America
4.3.3 North America Methane Mitigation Vaccine Market Size and Prospect (2026-2032)
4.4 Europe
4.4.1 Key Companies of Methane Mitigation Vaccine in Europe
4.4.2 Current Situation and Forecast of Methane Mitigation Vaccine in Europe
4.4.3 Europe Methane Mitigation Vaccine Market Size and Prospect (2026-2032)
4.5 Asia-Pacific
4.5.1 Key Companies of Methane Mitigation Vaccine in Asia-Pacific
4.5.2 Current Situation and Forecast of Methane Mitigation Vaccine in Asia-Pacific
4.5.3 Asia-Pacific Methane Mitigation Vaccine Market Size and Prospect (2026-2032)
4.5.4 China
4.5.5 Japan
4.5.6 South Korea
4.6 South America
4.6.1 Key Companies of Methane Mitigation Vaccine in South America
4.6.2 Current Situation and Forecast of Methane Mitigation Vaccine in South America
4.6.3 South America Methane Mitigation Vaccine Market Size and Prospect (2026-2032)
4.7 Middle East & Africa
4.7.1 Key Companies of Methane Mitigation Vaccine in Middle East & Africa
4.7.2 Current Situation and Forecast of Methane Mitigation Vaccine in Middle East & Africa
4.7.3 Middle East & Africa Methane Mitigation Vaccine Market Size and Prospect (2026-2032)
5 MARKET SIZE SEGMENT BY TYPE
5.1 Global Methane Mitigation Vaccine Market Forecast by Type (2026-2032)
5.2 Global Methane Mitigation Vaccine Market Share Forecast by Type (2026-2032)
6 MARKET SIZE SEGMENT BY APPLICATION
6.1 Global Methane Mitigation Vaccine Market Forecast by Application (2026-2032)
6.2 Global Methane Mitigation Vaccine Market Share Forecast by Application (2026-2032)
7 RESEARCH FINDINGS AND CONCLUSION
8 APPENDIX
8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer
1.1 Product Overview and Scope of Methane Mitigation Vaccine
1.2 Classification of Methane Mitigation Vaccine by Type
1.2.1 Overview: Global Methane Mitigation Vaccine Market Size by Type: 2026 Versus 2032
1.2.2 Global Methane Mitigation Vaccine Revenue Market Share by Type in 2032
1.2.3 Vaccines Targeting Methane-producing Archaea
1.2.4 Vaccines Modulating Immune Responses
1.3 Global Methane Mitigation Vaccine Market by Application
1.3.1 Overview: Global Methane Mitigation Vaccine Market Size by Application: 2026 Versus 2032
1.3.2 Cattle
1.3.3 Sheep
1.3.4 Other Ruminants
1.4 Global Methane Mitigation Vaccine Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
1.5.1 Methane Mitigation Vaccine Market Drivers
1.5.2 Methane Mitigation Vaccine Market Restraints
1.5.3 Methane Mitigation Vaccine Trends Analysis
2 COMPANY PROFILES
2.1 Lucidome Bio
2.1.1 Lucidome Bio Details
2.1.2 Lucidome Bio Major Business
2.1.3 Lucidome Bio Methane Mitigation Vaccine Product and Solutions
2.1.4 Lucidome Bio Recent Developments and Future Plans
2.2 ArkeaBio
2.2.1 ArkeaBio Details
2.2.2 ArkeaBio Major Business
2.2.3 ArkeaBio Methane Mitigation Vaccine Product and Solutions
2.2.4 ArkeaBio Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Methane Mitigation Vaccine Revenue and Share by Players (2026 & 2032)
3.2 Methane Mitigation Vaccine Players Head Office, Products and Services Provided
3.3 Methane Mitigation Vaccine Mergers & Acquisitions
3.4 Methane Mitigation Vaccine New Entrants and Expansion Plans
4 GLOBAL METHANE MITIGATION VACCINE FORECAST BY REGION
4.1 Global Methane Mitigation Vaccine Market Size by Region: 2026 VS 2032
4.2 Global Methane Mitigation Vaccine Market Size by Region, (2026-2032)
4.3 North America
4.3.1 Key Companies of Methane Mitigation Vaccine in North America
4.3.2 Current Situation and Forecast of Methane Mitigation Vaccine in North America
4.3.3 North America Methane Mitigation Vaccine Market Size and Prospect (2026-2032)
4.4 Europe
4.4.1 Key Companies of Methane Mitigation Vaccine in Europe
4.4.2 Current Situation and Forecast of Methane Mitigation Vaccine in Europe
4.4.3 Europe Methane Mitigation Vaccine Market Size and Prospect (2026-2032)
4.5 Asia-Pacific
4.5.1 Key Companies of Methane Mitigation Vaccine in Asia-Pacific
4.5.2 Current Situation and Forecast of Methane Mitigation Vaccine in Asia-Pacific
4.5.3 Asia-Pacific Methane Mitigation Vaccine Market Size and Prospect (2026-2032)
4.5.4 China
4.5.5 Japan
4.5.6 South Korea
4.6 South America
4.6.1 Key Companies of Methane Mitigation Vaccine in South America
4.6.2 Current Situation and Forecast of Methane Mitigation Vaccine in South America
4.6.3 South America Methane Mitigation Vaccine Market Size and Prospect (2026-2032)
4.7 Middle East & Africa
4.7.1 Key Companies of Methane Mitigation Vaccine in Middle East & Africa
4.7.2 Current Situation and Forecast of Methane Mitigation Vaccine in Middle East & Africa
4.7.3 Middle East & Africa Methane Mitigation Vaccine Market Size and Prospect (2026-2032)
5 MARKET SIZE SEGMENT BY TYPE
5.1 Global Methane Mitigation Vaccine Market Forecast by Type (2026-2032)
5.2 Global Methane Mitigation Vaccine Market Share Forecast by Type (2026-2032)
6 MARKET SIZE SEGMENT BY APPLICATION
6.1 Global Methane Mitigation Vaccine Market Forecast by Application (2026-2032)
6.2 Global Methane Mitigation Vaccine Market Share Forecast by Application (2026-2032)
7 RESEARCH FINDINGS AND CONCLUSION
8 APPENDIX
8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer
LIST OF TABLES
Table 1. Global Methane Mitigation Vaccine Revenue by Type, (USD Million) 2026 VS 2032
Table 2. Global Methane Mitigation Vaccine Revenue by Application, (USD Million), 2026 VS 2032
Table 3. Lucidome Bio Corporate Information, Head Office, and Major Competitors
Table 4. Lucidome Bio Major Business
Table 5. Lucidome Bio Methane Mitigation Vaccine Product and Solutions
Table 6. ArkeaBio Corporate Information, Head Office, and Major Competitors
Table 7. ArkeaBio Major Business
Table 8. ArkeaBio Methane Mitigation Vaccine Product and Solutions
Table 9. Global Methane Mitigation Vaccine Revenue (USD Million) by Players (2026 & 2032)
Table 10. Global Methane Mitigation Vaccine Revenue Share by Players (2026 & 2032)
Table 11. Methane Mitigation Vaccine Players Head Office, Products and Services Provided
Table 12. Methane Mitigation Vaccine Mergers & Acquisitions in the Past Five Years
Table 13. Methane Mitigation Vaccine New Entrants and Expansion Plans
Table 14. Global Market Methane Mitigation Vaccine Revenue (USD Million) Comparison by Region (2026 VS 2032)
Table 15. Global Methane Mitigation Vaccine Revenue Market Share by Region (2026-2032)
Table 16. Key Companies of Methane Mitigation Vaccine in North America
Table 17. Current Situation and Forecast of Methane Mitigation Vaccine in North America
Table 18. Key Companies of Methane Mitigation Vaccine in Europe
Table 19. Current Situation and Forecast of Methane Mitigation Vaccine in Europe
Table 20. Key Companies of Methane Mitigation Vaccine in Asia-Pacific
Table 21. Current Situation and Forecast of Methane Mitigation Vaccine in Asia-Pacific
Table 22. Key Companies of Methane Mitigation Vaccine in China
Table 23. Key Companies of Methane Mitigation Vaccine in Japan
Table 24. Key Companies of Methane Mitigation Vaccine in South Korea
Table 25. Key Companies of Methane Mitigation Vaccine in South America
Table 26. Current Situation and Forecast of Methane Mitigation Vaccine in South America
Table 27. Key Companies of Methane Mitigation Vaccine in Middle East & Africa
Table 28. Current Situation and Forecast of Methane Mitigation Vaccine in Middle East & Africa
Table 29. Global Methane Mitigation Vaccine Revenue Forecast by Type (2026-2032)
Table 30. Global Methane Mitigation Vaccine Revenue Forecast by Application (2026-2032)
Table 1. Global Methane Mitigation Vaccine Revenue by Type, (USD Million) 2026 VS 2032
Table 2. Global Methane Mitigation Vaccine Revenue by Application, (USD Million), 2026 VS 2032
Table 3. Lucidome Bio Corporate Information, Head Office, and Major Competitors
Table 4. Lucidome Bio Major Business
Table 5. Lucidome Bio Methane Mitigation Vaccine Product and Solutions
Table 6. ArkeaBio Corporate Information, Head Office, and Major Competitors
Table 7. ArkeaBio Major Business
Table 8. ArkeaBio Methane Mitigation Vaccine Product and Solutions
Table 9. Global Methane Mitigation Vaccine Revenue (USD Million) by Players (2026 & 2032)
Table 10. Global Methane Mitigation Vaccine Revenue Share by Players (2026 & 2032)
Table 11. Methane Mitigation Vaccine Players Head Office, Products and Services Provided
Table 12. Methane Mitigation Vaccine Mergers & Acquisitions in the Past Five Years
Table 13. Methane Mitigation Vaccine New Entrants and Expansion Plans
Table 14. Global Market Methane Mitigation Vaccine Revenue (USD Million) Comparison by Region (2026 VS 2032)
Table 15. Global Methane Mitigation Vaccine Revenue Market Share by Region (2026-2032)
Table 16. Key Companies of Methane Mitigation Vaccine in North America
Table 17. Current Situation and Forecast of Methane Mitigation Vaccine in North America
Table 18. Key Companies of Methane Mitigation Vaccine in Europe
Table 19. Current Situation and Forecast of Methane Mitigation Vaccine in Europe
Table 20. Key Companies of Methane Mitigation Vaccine in Asia-Pacific
Table 21. Current Situation and Forecast of Methane Mitigation Vaccine in Asia-Pacific
Table 22. Key Companies of Methane Mitigation Vaccine in China
Table 23. Key Companies of Methane Mitigation Vaccine in Japan
Table 24. Key Companies of Methane Mitigation Vaccine in South Korea
Table 25. Key Companies of Methane Mitigation Vaccine in South America
Table 26. Current Situation and Forecast of Methane Mitigation Vaccine in South America
Table 27. Key Companies of Methane Mitigation Vaccine in Middle East & Africa
Table 28. Current Situation and Forecast of Methane Mitigation Vaccine in Middle East & Africa
Table 29. Global Methane Mitigation Vaccine Revenue Forecast by Type (2026-2032)
Table 30. Global Methane Mitigation Vaccine Revenue Forecast by Application (2026-2032)
LIST OF FIGURES
Figure 1. Methane Mitigation Vaccine Picture
Figure 2. Global Methane Mitigation Vaccine Revenue Market Share by Type in 2032
Figure 3. Vaccines Targeting Methane-producing Archaea
Figure 4. Vaccines Modulating Immune Responses
Figure 5. Methane Mitigation Vaccine Revenue Market Share by Application in 2032
Figure 6. Cattle Picture
Figure 7. Sheep Picture
Figure 8. Other Ruminants Picture
Figure 9. Global Methane Mitigation Vaccine Market Size, (USD Million): 2026 VS 2032
Figure 10. Global Methane Mitigation Vaccine Revenue and Forecast (2026-2032) & (USD Million)
Figure 11. Methane Mitigation Vaccine Market Drivers
Figure 12. Methane Mitigation Vaccine Market Restraints
Figure 13. Methane Mitigation Vaccine Market Trends
Figure 14. Lucidome Bio Recent Developments and Future Plans
Figure 15. ArkeaBio Recent Developments and Future Plans
Figure 16. Global Methane Mitigation Vaccine Revenue Market Share by Region (2026-2032)
Figure 17. Global Methane Mitigation Vaccine Revenue Market Share by Region in 2032
Figure 18. North America Methane Mitigation Vaccine Revenue (USD Million) and Growth Rate (2026-2032)
Figure 19. Europe Methane Mitigation Vaccine Revenue (USD Million) and Growth Rate (2026-2032)
Figure 20. Asia-Pacific Methane Mitigation Vaccine Revenue (USD Million) and Growth Rate (2026-2032)
Figure 21. South America Methane Mitigation Vaccine Revenue (USD Million) and Growth Rate (2026-2032)
Figure 22. Middle East & Africa Methane Mitigation Vaccine Revenue (USD Million) and Growth Rate (2026-2032)
Figure 23. Global Methane Mitigation Vaccine Market Share Forecast by Type (2026-2032)
Figure 24. Global Methane Mitigation Vaccine Market Share Forecast by Application (2026-2032)
Figure 25. Methodology
Figure 26. Research Process and Data Source
Figure 1. Methane Mitigation Vaccine Picture
Figure 2. Global Methane Mitigation Vaccine Revenue Market Share by Type in 2032
Figure 3. Vaccines Targeting Methane-producing Archaea
Figure 4. Vaccines Modulating Immune Responses
Figure 5. Methane Mitigation Vaccine Revenue Market Share by Application in 2032
Figure 6. Cattle Picture
Figure 7. Sheep Picture
Figure 8. Other Ruminants Picture
Figure 9. Global Methane Mitigation Vaccine Market Size, (USD Million): 2026 VS 2032
Figure 10. Global Methane Mitigation Vaccine Revenue and Forecast (2026-2032) & (USD Million)
Figure 11. Methane Mitigation Vaccine Market Drivers
Figure 12. Methane Mitigation Vaccine Market Restraints
Figure 13. Methane Mitigation Vaccine Market Trends
Figure 14. Lucidome Bio Recent Developments and Future Plans
Figure 15. ArkeaBio Recent Developments and Future Plans
Figure 16. Global Methane Mitigation Vaccine Revenue Market Share by Region (2026-2032)
Figure 17. Global Methane Mitigation Vaccine Revenue Market Share by Region in 2032
Figure 18. North America Methane Mitigation Vaccine Revenue (USD Million) and Growth Rate (2026-2032)
Figure 19. Europe Methane Mitigation Vaccine Revenue (USD Million) and Growth Rate (2026-2032)
Figure 20. Asia-Pacific Methane Mitigation Vaccine Revenue (USD Million) and Growth Rate (2026-2032)
Figure 21. South America Methane Mitigation Vaccine Revenue (USD Million) and Growth Rate (2026-2032)
Figure 22. Middle East & Africa Methane Mitigation Vaccine Revenue (USD Million) and Growth Rate (2026-2032)
Figure 23. Global Methane Mitigation Vaccine Market Share Forecast by Type (2026-2032)
Figure 24. Global Methane Mitigation Vaccine Market Share Forecast by Application (2026-2032)
Figure 25. Methodology
Figure 26. Research Process and Data Source
